Thu, February 23, 2023
Wed, February 22, 2023
Tue, February 21, 2023
Mon, February 20, 2023
Fri, February 17, 2023

Edward Nash Maintained (TVTX) at Strong Buy with Increased Target to $44 on, Feb 22nd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-44-on-feb-22nd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Edward Nash of Canaccord Genuity, Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Increased Target from $40 to $44 on, Feb 22nd, 2023.

Edward has made no other calls on TVTX in the last 4 months.



There are 5 other peers that have a rating on TVTX. Out of the 5 peers that are also analyzing TVTX, 1 agrees with Edward's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Alex Thompson of "Stifel" Initiated at Hold and Held Target at $22 on, Wednesday, December 14th, 2022


These are the ratings of the 4 analyists that currently disagree with Edward


  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $31 on, Tuesday, February 21st, 2023
  • Do Kim of "Piper Sandler" Maintained at Buy with Increased Target to $46 on, Tuesday, February 21st, 2023
  • Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $40 on, Tuesday, February 21st, 2023
  • Laura Chico of "Wedbush" Upgraded from Hold to Buy and Held Target at $30 on, Tuesday, February 21st, 2023

Publication Contributing Sources